According to Accord BioPharma, #Imuldosa prefilled syringes will be available at a 92% discount to Stelara and at a 33% discount for the vial formulation.

Read More: www.gastroenterologyadvisor.com/news/ustekinumab-biosimi...

Accord BioPharma Launches IMULDOSA® at Unmatched Price for Patients Needing Treatment Accord BioPharma introduces IMULDOSA®, a biosimilar to STELARA®, with a significant price reduction to enhance accessibility for patients in need.

Accord BioPharma Launches IMULDOSA® at Unmatched Price for Patients Needing Treatment #United_States #Raleigh #Accord_BioPharma #Imuldosa #Ustekinumab

Accord Healthcare Secures European Approval for Imuldosa®, a Promising Biosimilar to Stelara® Accord Healthcare has received marketing authorization for its biosimilar Imuldosa®, intended for treating immune-mediated inflammatory diseases in Europe.

Accord Healthcare Secures European Approval for Imuldosa®, a Promising Biosimilar to Stelara® #London #United_Kingdom #Stelara #Accord_Healthcare #Imuldosa